Overview
Gadobenate dimeglumine is a gadolinium based MRI agent with higher relaxivity and partial hepatobiliary uptake compared with standard extracellular agents.
Properties
Enhanced relaxivity improves lesion conspicuity; partial protein binding and hepatocyte uptake provide additional liver lesion characterization.
Uses
Used for brain and body MRI and for improved detection and characterization of liver lesions in selected protocols.
Safety
Screen renal function prior to administration; macrocyclic agents may be preferred in patients at high risk for gadolinium retention.